Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Published:2018-07-24 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Sosa Iglesias Venus,Giuranno Lorena,Dubois Ludwig J.,Theys Jan,Vooijs Marc

Funder

FP7 Ideas: European Research Council

Association for International Cancer Research

H2020 Marie Skłodowska-Curie Actions

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference209 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Auperin;J Clin Oncol,2010

2. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group;Huber;J Clin Oncol,2006

3. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer;Ceresoli;Lung Cancer,2004

4. The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer;Weiss;Ann Oncol,2007

5. Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study;Veronesi;Am J Clin Oncol,1988

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent development of Schiff-base metal complexes as therapeutic agents for lung cancer;Journal of Molecular Structure;2024-12

2. Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy;European Journal of Medicinal Chemistry;2024-10

3. Design, synthesis and anticancer activity of β-carboline based pseudo-natural products by inhibiting AKT/mTOR signaling pathway;Bioorganic Chemistry;2024-10

4. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer;Translational Research;2024-10

5. Cancer cell-derived exosomes promote NSCLC progression via the miR-199b-5p/HIF1AN axis;Molecular Immunology;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3